These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

719 related items for PubMed ID: 16822236

  • 1. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M, Inazu A, Katsuda S, Miwa K, Kawashiri MA, Nohara A, Higashikata T, Kobayashi J, Mabuchi H, Yamagishi M.
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [Abstract] [Full Text] [Related]

  • 2. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H, Miyazaki R, Imura T, Masunaga S, Shimada A, Mikami D, Kasuno K, Takahashi N, Hirano T, Yoshida H.
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [Abstract] [Full Text] [Related]

  • 3. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S, Ademoglu E, Gurdol F, Mutlu-Turkoglu U, Bilge AK, Nisanci Y.
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [Abstract] [Full Text] [Related]

  • 4. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
    Frisdal E, Klerkx AH, Le Goff W, Tanck MW, Lagarde JP, Jukema JW, Kastelein JJ, Chapman MJ, Guerin M.
    Hum Mol Genet; 2005 Sep 15; 14(18):2607-18. PubMed ID: 16049032
    [Abstract] [Full Text] [Related]

  • 5. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S, Tiret L, Bickel C, Schlitt A, Jungmair W, Genth-Zotz S, Lubos E, Espinola-Klein C, Rupprecht HJ.
    Z Kardiol; 2004 Sep 15; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [Abstract] [Full Text] [Related]

  • 6. Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population.
    Inazu A, Nishimura Y, Terada Y, Mabuchi H.
    J Hum Genet; 2001 Sep 15; 46(4):172-7. PubMed ID: 11322655
    [Abstract] [Full Text] [Related]

  • 7. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
    Dullaart RP, Borggreve SE, Hillege HL, Dallinga-Thie GM.
    Scand J Clin Lab Invest; 2008 Sep 15; 68(2):99-105. PubMed ID: 17852818
    [Abstract] [Full Text] [Related]

  • 8. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia.
    Inazu A, Koizumi J, Mabuchi H, Kajinami K, Takeda R.
    Horm Metab Res; 1992 Jun 15; 24(6):284-8. PubMed ID: 1634194
    [Abstract] [Full Text] [Related]

  • 9. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF, Muhlestein JB, Horne BD, Hart NI, Bair TL, Molhuizen HO, Anderson JL.
    Am Heart J; 2003 Dec 15; 146(6):1007-14. PubMed ID: 14660992
    [Abstract] [Full Text] [Related]

  • 10. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.
    Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI, Kastelein JJ.
    N Engl J Med; 1998 Jan 08; 338(2):86-93. PubMed ID: 9420339
    [Abstract] [Full Text] [Related]

  • 11. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
    van Acker BA, Botma GJ, Zwinderman AH, Kuivenhoven JA, Dallinga-Thie GM, Sijbrands EJ, Boer JM, Seidell JC, Jukema JW, Kastelein JJ, Jansen H, Verhoeven AJ, REGRESS Study Group.
    Atherosclerosis; 2008 Sep 08; 200(1):161-7. PubMed ID: 18164013
    [Abstract] [Full Text] [Related]

  • 12. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P, Mensink RP, Hornstra G.
    Nutr Metab Cardiovasc Dis; 2002 Dec 08; 12(6):317-24. PubMed ID: 12669678
    [Abstract] [Full Text] [Related]

  • 13. Common variants of Cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population.
    Padmaja N, Ravindra Kumar M, Soya SS, Adithan C.
    Clin Chim Acta; 2007 Jan 08; 375(1-2):140-6. PubMed ID: 16890925
    [Abstract] [Full Text] [Related]

  • 14. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
    de Grooth GJ, Zerba KE, Huang SP, Tsuchihashi Z, Kirchgessner T, Belder R, Vishnupad P, Hu B, Klerkx AH, Zwinderman AH, Jukema JW, Sacks FM, Kastelein JJ, Kuivenhoven JA.
    J Am Coll Cardiol; 2004 Mar 03; 43(5):854-7. PubMed ID: 14998629
    [Abstract] [Full Text] [Related]

  • 15. Taq1B polymorphism of cholesteryl ester transfer protein (CETP) gene in primary combined hyperlipidaemia.
    Hassanzadeh T, Firoozrai M, Zonouz AE, Zavarehee A, Paoli M.
    Indian J Med Res; 2009 Mar 03; 129(3):293-8. PubMed ID: 19491422
    [Abstract] [Full Text] [Related]

  • 16. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients.
    Yilmaz H, Isbir T, Agachan B, Karaali ZE.
    Cell Biochem Funct; 2005 Mar 03; 23(1):23-8. PubMed ID: 15386541
    [Abstract] [Full Text] [Related]

  • 17. Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus.
    Hsieh MC, Tien KJ, Chang SJ, Lo CS, Hsin SC, Hsiao JY, Hsu SC, Liang HT, Chen HC, Shin SJ, Lin SR.
    Metabolism; 2007 Jun 03; 56(6):745-50. PubMed ID: 17512305
    [Abstract] [Full Text] [Related]

  • 18. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease.
    Horne BD, Camp NJ, Anderson JL, Mower CP, Clarke JL, Kolek MJ, Carlquist JF, Intermountain Heart Collaborative Study Group.
    J Am Coll Cardiol; 2007 May 22; 49(20):2053-60. PubMed ID: 17512363
    [Abstract] [Full Text] [Related]

  • 19. Relationship between a novel polymorphism of hepatic lipase gene and coronary artery disease.
    Su ZG, Zhang SZ, Hou YP, Zhang L, Huang DJ, Liao LC, Xiao CY.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov 22; 34(6):780-5. PubMed ID: 12417924
    [Abstract] [Full Text] [Related]

  • 20. Cholesteryl ester transfer protein gene polymorphisms are associated with coronary artery disease in Corsican population (France).
    Falchi A, Piras IS, Vona G, Amoros JP, Calo' CM, Giovannoni L, Varesi L.
    Exp Mol Pathol; 2007 Aug 22; 83(1):25-9. PubMed ID: 17275808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.